A quantitative theory is proposed for the nonexponential NMR proton signal decay observed in liver with iron overload or superparamagnetic iron oxide particles. This effect occurs for Carr-Purcell-Meiboom-Gill (CPMG) sequences and is argued to be a direct consequence of the strong magnetic field inh
Biodistribution of ultrasmall iron oxide particles in the rat liver
β Scribed by Bernard E. Van Beers; Christine Sempoux; Roland Materne; Monique Delos; Anne M. Smith
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 335 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Ferumoxtran, an ultrasmall superparamagnetic iron oxide particle, can be located in several tissue compartments in the liver, namely the extracellular space (blood and interstitium), reticuloendothelial cells, and possibly hepatocytes. To better understand the compartmental distribution of ferumoxtran in the liver, we performed a longitudinal study in the rat using microscopy and magnetic resonance imaging. At light microscopy, no substantial cellular uptake of ferumoxtran was observed before one hour after injection. With a dose of 15 ΞΌmol Fe/kg, the number of ferumoxtran particles in the reticuloendothelial cells peaked between one and four hours and with a 150 ΞΌmol Fe/kg dose, it peaked between eight and 24 hours. Within hepatocytes, only sparse particles were observed with electron microscopy, at a dose of 150 ΞΌmol Fe/kg. Imaging performed up until one hour after ferumoxtran injection showed a significant increase in liver signal intensity on T1βweighted images. These results suggest that ferumoxtran mainly acts as an extracellular agent for at least one hour in the rat and that reticuloendothelial accumulation peaks at later time points. Substantial uptake within hepatocytes did not occur. J. Magn. Reson. Imaging 2001;13:594β599. Β© 2001 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract Ultrasmall superparamagnetic iron oxide nanoparticles have been widely used during the past decade as MR intravascular contrast agents in the study of animal models. Such agents enhance both __T__~1~ and __T__~2~/__T__~2~\* relaxation, although for animal studies it is the later type of
## Abstract The purpose of this study was to evaluate the diagnostic efficacy and safety of an intravenous injection of magnetic resonance imaging (MRI) contrast agent, SH U 555 A, in adult patients with known focal liver lesions. Preβ and postβcontrast image sets were obtained in 19 patients after
The purpose of this study was to determine the dependency of liver-and spleen-enhancement on particle size and dose of bolus-injectable iron oxides designed for bloodpool MR-angiography (MRA). The superparamagnetic iron oxide SHU 555 A [particle size 65 nm (group 1)] and three derivatives designed f